<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>17091864</identifier>
<setSpec>0303-8874</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Prim Espada, M P</dc:author>
<dc:author>Pérez Mora, R</dc:author>
<dc:author>de Diego Sastre, J I</dc:author>
<dc:description xml:lang="en">In order to assess a cost analysis in the management of recurrent acute otitis media (RAOM) in children, we performed a prospective study with data obtained from 80 patients with RAOM, evaluated between january 1998 and february 2000. A good outcome with the antibiotic prophylaxis was obtained in 67 cases (83,7%), with either amoxicillin or azythromicin. Applying the model of assumptions the control of RAOM with ear tube insertion was obtained in 66 children (82,5%). Thus, the cost of antibiotic chemoprophylaxis was Euro 83,60 for the amoxicillin patients and Euro 116,60 for the azythromicin ones. Surgical approach of this entity with the use of ear tubes costs Euro 392,95 per case. To sum up, in pediatric patients, without medical contraindications, the initial treatment for RAOM is chemoprophylaxis, with ear tubes reserved its failure.</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:date>2006 </dc:date>
<dc:title xml:lang="es">Análisis comparativo de los costos terapéuticos para el control de la otitis media aguda de repetición.</dc:title>
<dc:title xml:lang="en">[Comparative analysis of the therapeutic costs to control the recurrent acute otitis media].</dc:title>
<dc:publisher>Anales otorrinolaringologicos ibero-americanos</dc:publisher>
</metadata>
</record>
</pubmed-document>
